HPV Vaccine Journey

The link between HPV and cervical cancer was solidified in the mid-nineties, despite initial skepticism from both pharmaceutical companies and the scientific community. Key breakthroughs in the 1980s led to the development of the HPV vaccine Gardasil, which faced significant controversy upon its FDA approval in 2006. The discussion highlights the impact of targeted messaging and the ongoing challenges in vaccine acceptance and effectiveness over the years.